Cryo-EM structure of a light chain-derived amyloid fibril from a patient with systemic AL amyloidosis von Radamaker, Lynn, Lin, Yin-Hsi, Annamalai, Karthikeyan, Huhn, Stefanie, Hegenbart, Ute, Schönland, Stefan O., Fritz, Günter, Schmidt, Matthias, Fändrich, Marcus

Volltext

Prognosis and Staging of AL Amyloidosis von Dittrich, Tobias, Kimmich, Christoph, Hegenbart, Ute, Schönland, Stefan O.

Volltext

Role of mutations and post-translational modifications in systemic AL amyloidosis studied by cryo-EM von Radamaker, Lynn, Karimi-Farsijani, Sara, Andreotti, Giada, Baur, Julian, Neumann, Matthias, Schreiner, Sarah, Berghaus, Natalie, Motika, Raoul, Haupt, Christian, Walther, Paul, Schmidt, Volker, Huhn, Stefanie, Hegenbart, Ute, Schönland, Stefan O., Wiese, Sebastian, Read, Clarissa, Schmidt, Matthias, Fändrich, Marcus

Volltext

A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis von Sanchorawala, Vaishali, Palladini, Giovanni, Kukreti, Vishal, Zonder, Jeffrey A., Cohen, Adam D., Seldin, David C., Dispenzieri, Angela, Jaccard, Arnaud, Schönland, Stefan O., Berg, Deborah, Yang, Huyuan, Gupta, Neeraj, Hui, Ai-Min, Comenzo, Raymond L., Merlini, Giampaolo

Volltext

Clarification on the definition of complete haematologic response in light-chain (AL) amyloidosis von Palladini, Giovanni, Schoenland, Stefan O., Sanchorawala, Vaishali, Kumar, Shaji, Wechalekar, Ashutosh, Hegenbart, Ute, Milani, Paolo, Ando, Yukio, Westermark, Per, Dispenzieri, Angela, Merlini, Giampaolo

Volltext

Analysis of the complete lambda light chain germline usage in patients with AL amyloidosis and dominant heart or kidney involvement von Berghaus, Natalie, Schreiner, Sarah, Granzow, Martin, Müller-Tidow, Carsten, Hegenbart, Ute, Schönland, Stefan O, Huhn, Stefanie

Volltext

Light chain mutations contribute to defining the fibril morphology in systemic AL amyloidosis von Karimi-Farsijani, Sara, Pfeiffer, Peter Benedikt, Banerjee, Sambhasan, Baur, Julian, Kuhn, Lukas, Kupfer, Niklas, Hegenbart, Ute, Schönland, Stefan O., Wiese, Sebastian, Haupt, Christian, Schmidt, Matthias, Fändrich, Marcus

Volltext

Common transthyretin-derived amyloid fibril structures in patients with hereditary ATTR amyloidosis von Steinebrei, Maximilian, Baur, Julian, Pradhan, Anaviggha, Kupfer, Niklas, Wiese, Sebastian, Hegenbart, Ute, Schönland, Stefan O., Schmidt, Matthias, Fändrich, Marcus

Volltext

Immunohistochemistry in the classification of systemic forms of amyloidosis: a systematic investigation of 117 patients von Schönland, Stefan O., Hegenbart, Ute, Bochtler, Tilmann, Mangatter, Anja, Hansberg, Marion, Ho, Anthony D., Lohse, Peter, Röcken, Christoph

Volltext

Cryo-EM structure of a lysozyme-derived amyloid fibril from hereditary amyloidosis von Karimi-Farsijani, Sara, Sharma, Kartikay, Ugrina, Marijana, Kuhn, Lukas, Pfeiffer, Peter Benedikt, Haupt, Christian, Wiese, Sebastian, Hegenbart, Ute, Schönland, Stefan O., Schwierz, Nadine, Schmidt, Matthias, Fändrich, Marcus

Volltext

Improved outcomes after heart transplantation for cardiac amyloidosis in the modern era von Kristen, Arnt V., Kreusser, Michael M., Blum, Patrick, Schönland, Stefan O., Frankenstein, Lutz, Dösch, Andreas O., Knop, Benjamin, Helmschrott, Matthias, Schmack, Bastian, Ruhparwar, Arjang, Hegenbart, Ute, Katus, Hugo A., Raake, Philip W.J.

Volltext

Letermovir prophylaxis is effective in preventing cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: single-center real-world data von Derigs, Patrick, Radujkovic, Aleksandar, Schubert, Maria-Luisa, Schnitzler, Paul, Schöning, Tilman, Müller-Tidow, Carsten, Hegenbart, Ute, Schönland, Stefan O., Luft, Thomas, Dreger, Peter, Schmitt, Michael

Volltext

Sural nerve injury in familial amyloid polyneuropathy: MR neurography vs clinicopathologic tools von Kollmer, Jennifer, Sahm, Felix, Hegenbart, Ute, Purrucker, Jan C, Kimmich, Christoph, Schönland, Stefan O, Hund, Ernst, Heiland, Sabine, Hayes, John M, Kristen, Arnt V, Röcken, Christoph, Pham, Mirko, Bendszus, Martin, Weiler, Markus

Volltext

Performance analysis of AL amyloidosis cardiac biomarker staging systems with special focus on renal failure and atrial arrhythmia von Dittrich, Tobias, Benner, Axel, Kimmich, Christoph, Siepen, Fabian Aus dem, Veelken, Kaya, Kristen, Arnt V, Bochtler, Tilmann, Katus, Hugo A, Müller-Tidow, Carsten, Hegenbart, Ute, Schönland, Stefan O

Volltext

Lenalidomide/melphalan/dexamethasone in newly diagnosed patients with immunoglobulin light chain amyloidosis: results of a prospective phase 2 study with long-term follow up von Hegenbart, Ute, Bochtler, Tilmann, Benner, Axel, Becker, Natalia, Kimmich, Christoph, Kristen, Arnt V, Beimler, Jörg, Hund, Ernst, Zorn, Markus, Freiberger, Anja, Gawlik, Marianne, Goldschmidt, Hartmut, Hose, Dirk, Jauch, Anna, Ho, Anthony D, Schönland, Stefan O

Volltext

Quality of life and symptoms among patients with relapsed/refractory AL amyloidosis treated with ixazomib‐dexamethasone versus physician's choice von Sanchorawala, Vaishali, Wechalekar, Ashutosh D., Kim, Kihyun, Schönland, Stefan O., Landau, Heather J., Kwok, Fiona, Suzuki, Kenshi, Dispenzieri, Angela, Merlini, Giampaolo, Comenzo, Raymond L., Cherepanov, Dasha, Hayden, Vanessa C., Kumar, Arun, Labotka, Richard, Faller, Douglas V., Kastritis, Efstathios

Volltext

A novel risk score to predict survival in advanced heart failure due to cardiac amyloidosis von Kreusser, Michael M., Volz, Martin J., Knop, Benjamin, Ehlermann, Philipp, Schmack, Bastian, Ruhparwar, Arjang, Hegenbart, Ute, Schönland, Stefan O., Katus, Hugo A., Raake, Philip W.

Volltext

Novel recurrent chromosomal aberrations detected in clonal plasma cells of light chain amyloidosis patients show potential adverse prognostic effect: first results from a genome-wi... von Granzow, Martin, Hegenbart, Ute, Hinderhofer, Katrin, Hose, Dirk, Seckinger, Anja, Bochtler, Tilmann, Hemminki, Kari, Goldschmidt, Hartmut, Schönland, Stefan O, Jauch, Anna

Volltext

Systemic immunoglobulin light chain amyloidosis von Merlini, Giampaolo, Dispenzieri, Angela, Sanchorawala, Vaishali, Schönland, Stefan O., Palladini, Giovanni, Hawkins, Philip N., Gertz, Morie A.

Volltext

HOVON 104, long‐term follow‐up of bortezomib‐dexamethasone induction therapy followed by autologous stem cell transplantation in newly diagnosed AL amyloidosis patients von Minnema, Monique C., Nasserinejad, Kazem, Hegenbart, Ute, Ypma, Paula F., Wu, Ka Lung, Kersten, Marie Jose, Croockewit, Sandra, Zweegman, Sonja, Tick, Lidwine, Broijl, Annemiek, Koene, Harry, Bos, Gerard M. J., Sonneveld, Pieter, Schönland, Stefan O.

Volltext